Abstracts/Presentation Description
Join Prof. Clare Scott as she explores the evolving role of predictive biomarkers in ovarian and rare cancers, offering insights from a medical oncologist’s perspective. Prof. Scott will provide a unique blend of research-driven insights and clinical experience, offering valuable takeaways for healthcare professionals focused on advancing cancer care. This session will cover:
- The significance of predictive biomarkers in guiding personalised treatment approaches.
- Emerging biomarkers in ovarian and rare cancers that are reshaping diagnostic and therapeutic strategies.
- Clinical challenges and opportunities in implementing biomarker-driven care for these complex cancers.
- Future directions for integrating predictive biomarkers into precision oncology to improve patient outcomes.